ANIX
ANIX
Healthcare — PHARMACEUTICAL PREPARATIONS
Valhalla Score
—
A proprietary composite score from 0–100 measuring a stock's technical strength, sector-relative performance, and institutional flow activity. Higher scores indicate stronger setups.
—
—
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
📊 Key Statistics
Market Cap$94M
P/E Ratio—
EPS (TTM)—
EPS YoY—
Revenue YoY—
Float—
Short Float %—
Inst. Ownership—
Sector RS—
📈 Fundamentals
ROE—
ROIC—
ROA—
Current Ratio—
Debt/Equity—
Gross Margin—
Net Margin—
Dividend Yield—
Next Earnings—
⚡ Options Summary
Call OI—
Put OI—
P/C Ratio (OI)—
Gamma Environment—
Max Pain—
Call Wall—
Put Wall—
🎯 Analyst Estimates
Consensus Target—
High Target—
Low Target—
Analysts—
Upside/Downside—
📋 Quarterly Financials
| Period | Revenue | Rev YoY | EPS | EPS YoY | Gross Margin |
|---|
🔥 Recent Options Flow
| Type | Strike | Exp | Size | Premium | Time |
|---|
🏛️ Institutional Trades
| Type | Price | Size | Value | Venue | Time |
|---|
👤 Insider Trades
| Name | Type | Shares | Price | Date |
|---|
🏦 Top Institutional Holders
| Institution | Shares | Value | % of Class |
|---|